24 May 2013
Keywords: unimed, antiparasitic, agent, ntz, phase, iii, news
Article | 15 January 1996
- A Phase III trial of Unimed Pharmaceuticals' antiparasitic agent NTZ
(nitazoxanide) has begun in Mexico. The study will assess the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
25 March 1996
25 September 1995
23 May 2013
© 2013 thepharmaletter.com